Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
Journal: Cancer
Published: December 07, 2016
Immune checkpoint blockade and interferon-α in melanoma.
Journal: Seminars in oncology
Published: May 13, 2015
Showing 1-2 of 2
Last Updated: 09/26/2026